Search | Page 25 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. MDS Patient Becomes a Role Model

    ... in my mother’s footsteps, in November of 2013 I had chemotherapy and radiation followed by a bone marrow transplant from an ... in my feet (tingling, pain, numbness or weakness) from the chemotherapy, radiation, and all of the medication I had to take for the ...

    Patient Chronicle last updated 04/22/2016 - 5:19pm.

  2. TCRαβ+/CD19+ Depleted Haploidentical HSCT + Zoledronate

    ... metastases and did not achieve a CR with surgery and/or chemotherapy Karnofsky (patients > 16 years) or Lansky ... have fully recovered from acute toxic effects of all prior chemotherapy, immunotherapy, or radiotherapy prior to entering this study ...

    Clinical Trial last updated 04/29/2016 - 4:35pm.

  3. Options for MDS patients beyond HMAs

    ... including:  low dose cytarabine; aggressive chemotherapy ; switching to the other of the two HMAs – preferably ...

    Research Review last updated 05/02/2016 - 9:09am.

  4. What are the treatments for MDS?

    ... (Dacogen) and azacitidine (Vidaza). Chemotherapy :  Treats MDS by using drugs that kill abnormal cells. ...

    FAQ last updated 03/15/2016 - 11:31pm.

  5. Chronic Myeloproliferative Neoplasms (MPN)

    ... patients with this condition. Some of them are: Chemotherapy , such as the drug hydroxyurea (known ashydroxycarbamide in ...

    Topic section last updated 07/07/2016 - 3:19pm.

  6. Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor

    ... NHL in remission which is considered not curable with chemotherapy alone and not eligible/appropriate for autologous transplant. ...

    Clinical Trial last updated 04/29/2016 - 1:59pm.

  7. Heather Putney’s Trials (and Travels) with Aplastic Anemia

    ... My husband and I understood that due to the limited chemotherapy , I had a 50% chance of maintaining fertility.  Prior the ...

    Patient Chronicle last updated 08/15/2016 - 8:42am.

  8. SL-401 in Advanced, High Risk Myeloproliferative Neoplasms (Systemic Mastocytosis, Advanced Symptomatic Hypereosinoophic Disorder, Myelofibrosis, Chronic Myelomonocytic Leukemia)

    ... significant toxicities Grade ≥2 from previous chemotherapy not readily controlled by supportive measures (excluding ... nausea, and fatigue) Patient has received treatment with chemotherapy, wide-field radiation, or biologic therapy within 14 days of study ...

    Clinical Trial last updated 06/06/2016 - 2:11pm.

  9. PRO#1278: Fludarabine and Busulfan vs. Fludarabine, Busulfan and Total Body Irradiation (FLUBUTBI)

    ... disorder, or myelodysplastic syndrome Chemotherapy or radiotherapy within 14 days of initiating treatment in this ...

    Clinical Trial last updated 04/29/2016 - 3:09pm.

  10. Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide

    ... One of the following: Cytotoxic chemotherapy , alemtuzumab , or an adequate course of 5- ...

    Clinical Trial last updated 05/02/2016 - 2:38pm.